共 23 条
- [21] CD28 expression on multiple myeloma cells enhances the cytotoxic activity of CD38/CD28xCD3 trispecific T cell engagerCANCER RESEARCH, 2020, 80 (16)El-Murr, Nizar论文数: 0 引用数: 0 h-index: 0机构: Sanofi Oncol Res, Vitry Sur Seine, France Sanofi Oncol Res, Vitry Sur Seine, FranceHenry, Christophe论文数: 0 引用数: 0 h-index: 0机构: Sanofi Oncol Res, Vitry Sur Seine, France Sanofi Oncol Res, Vitry Sur Seine, FranceFrancesconi, Elisa论文数: 0 引用数: 0 h-index: 0机构: Sanofi Oncol Res, Vitry Sur Seine, France Sanofi Oncol Res, Vitry Sur Seine, FranceAttenot, Florence论文数: 0 引用数: 0 h-index: 0机构: Sanofi Oncol Res, Vitry Sur Seine, France Sanofi Oncol Res, Vitry Sur Seine, FranceVirone-Oddos, Angela论文数: 0 引用数: 0 h-index: 0机构: Sanofi Oncol Res, Vitry Sur Seine, France Sanofi Oncol Res, Vitry Sur Seine, FranceVidard, Laurent论文数: 0 引用数: 0 h-index: 0机构: Sanofi Oncol Res, Vitry Sur Seine, France Sanofi Oncol Res, Vitry Sur Seine, FranceWu, Lan论文数: 0 引用数: 0 h-index: 0机构: Sanofi Oncol Res, Cambridge, MA USA Sanofi Oncol Res, Vitry Sur Seine, FranceYang, Zhi-Yong论文数: 0 引用数: 0 h-index: 0机构: Sanofi Oncol Res, Cambridge, MA USA Sanofi Oncol Res, Vitry Sur Seine, FranceChiron, Marielle论文数: 0 引用数: 0 h-index: 0机构: Sanofi Oncol Res, Vitry Sur Seine, France Sanofi Oncol Res, Vitry Sur Seine, France
- [22] Efficacy of Daratumumab-Based Regimens in Anti-CD38 Treatment-Naive Relapsed/Refractory Multiple Myeloma with High-Risk CytogeneticsBLOOD, 2023, 142Snyder, Jordan论文数: 0 引用数: 0 h-index: 0机构: US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USA Univ Kansas, Med Ctr, Div Hematol Malignancies & Cellular Therapeut, Westwood, KS USA US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USAMansour, Razan论文数: 0 引用数: 0 h-index: 0机构: US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USA Univ Kansas, Internal Med, Med Ctr, Kansas City, KS USA US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USAMammadzadeh, Aytaj论文数: 0 引用数: 0 h-index: 0机构: US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USA Mayo Clin, Div Hematol Oncol, Rochester, MN USA US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USAHashmi, Hamza论文数: 0 引用数: 0 h-index: 0机构: US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USA Med Univ South Carolina, Charleston, SC 29425 USA US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USAAfrough, Aimaz论文数: 0 引用数: 0 h-index: 0机构: US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USA Univ Texas Southwestern Med Ctr Dallas, Hematol Malignancies & Cellular Therapy, Dallas, TX 75390 USA US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USAAlkharabsheh, Omar论文数: 0 引用数: 0 h-index: 0机构: US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USA Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36688 USA US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USAPaul, Barry论文数: 0 引用数: 0 h-index: 0机构: US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USA Atrium Hlth, Levine Canc Inst, Plasma Cell Disorders Sect, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USA US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USAAtrash, Shebli论文数: 0 引用数: 0 h-index: 0机构: US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USA Atrium Hlth, Levine Canc Inst, Plasma Cell Disorders Sect, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USA US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USAMushtaq, Muhammad Umair论文数: 0 引用数: 0 h-index: 0机构: US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USA Univ Kansas, Med Ctr, Div Hematol Malignancies & Cellular Therapeut, Westwood, KS USA US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USASkikne, Barry S.论文数: 0 引用数: 0 h-index: 0机构: US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USA Univ Kansas, Med Ctr, Div Hematol Malignancies & Cellular Therapeut, Westwood, KS USA US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USAAhmed, Nausheen论文数: 0 引用数: 0 h-index: 0机构: US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USA Univ Kansas, Med Ctr, Div Hematol Malignancies & Cellular Therapeut, Westwood, KS USA US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USAAbdallah, Al-Ola论文数: 0 引用数: 0 h-index: 0机构: US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USA Univ Kansas, Med Ctr, Div Hematol Malignancies & Cellular Therapeut, Westwood, KS USA US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USA
- [23] Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab (vol 35, pg 201, 2021)LEUKEMIA, 2022, 36 (01) : 297 - 297Garcia-Guerrero, Estefania论文数: 0 引用数: 0 h-index: 0机构: Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla,Instituto de Biomedicina de Sevilla (IBIS)Gotz, Ralph论文数: 0 引用数: 0 h-index: 0机构: Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla,Instituto de Biomedicina de Sevilla (IBIS)Doose, Soren论文数: 0 引用数: 0 h-index: 0机构: Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla,Instituto de Biomedicina de Sevilla (IBIS)Sauer, Markus论文数: 0 引用数: 0 h-index: 0机构: Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla,Instituto de Biomedicina de Sevilla (IBIS)Rodriguez-Gil, Alfonso论文数: 0 引用数: 0 h-index: 0机构: Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla,Instituto de Biomedicina de Sevilla (IBIS)Nerreter, Thomas论文数: 0 引用数: 0 h-index: 0机构: Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla,Instituto de Biomedicina de Sevilla (IBIS)Kortum, K. Martin论文数: 0 引用数: 0 h-index: 0机构: Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla,Instituto de Biomedicina de Sevilla (IBIS)Perez-Simon, Jose A.论文数: 0 引用数: 0 h-index: 0机构: Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla,Instituto de Biomedicina de Sevilla (IBIS)Einsele, Hermann论文数: 0 引用数: 0 h-index: 0机构: Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla,Instituto de Biomedicina de Sevilla (IBIS)Hudecek, Michael论文数: 0 引用数: 0 h-index: 0机构: Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla,Instituto de Biomedicina de Sevilla (IBIS)Danhof, Sophia论文数: 0 引用数: 0 h-index: 0机构: Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla,Instituto de Biomedicina de Sevilla (IBIS)